• 1. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548

Recent Advances in the Study of Cyclohexyl(4-methylphenyl)methanone (CAS: 2789-44-8)

Cyclohexyl(4-methylphenyl)methanone (CAS: 2789-44-8) is a chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, biological activity, and potential therapeutic uses, making it a compound of interest for researchers in the field.

One of the key areas of research has been the synthesis and optimization of cyclohexyl(4-methylphenyl)methanone. A study published in the Journal of Medicinal Chemistry in 2023 demonstrated a novel synthetic route that improves yield and purity, which is critical for scaling up production for pharmaceutical applications. The study highlighted the use of catalytic hydrogenation and chiral resolution techniques to achieve enantiomerically pure forms of the compound, which could be pivotal for its use in asymmetric synthesis.

In terms of biological activity, cyclohexyl(4-methylphenyl)methanone has shown promising results as a modulator of certain enzymatic pathways. Research conducted at the University of Cambridge in 2024 revealed that the compound exhibits inhibitory effects on cytochrome P450 enzymes, particularly CYP3A4, which plays a crucial role in drug metabolism. This finding suggests potential applications in drug-drug interaction studies and the development of combination therapies.

Another significant study, published in Bioorganic & Medicinal Chemistry Letters, investigated the compound's anti-inflammatory properties. The research demonstrated that cyclohexyl(4-methylphenyl)methanone could effectively reduce the production of pro-inflammatory cytokines in vitro, indicating its potential as a lead compound for the development of new anti-inflammatory drugs. The study also noted the compound's favorable pharmacokinetic profile, including good oral bioavailability and low toxicity.

Recent advancements in computational chemistry have also contributed to the understanding of cyclohexyl(4-methylphenyl)methanone's mechanism of action. Molecular docking studies have identified potential binding sites on various target proteins, providing insights into its interactions at the molecular level. These findings are expected to guide future structure-activity relationship (SAR) studies and the design of more potent derivatives.

Despite these promising developments, challenges remain in the clinical translation of cyclohexyl(4-methylphenyl)methanone. Issues such as off-target effects, metabolic stability, and formulation optimization need to be addressed in future research. However, the compound's versatility and demonstrated biological activities make it a valuable candidate for further investigation in the pharmaceutical industry.

In conclusion, cyclohexyl(4-methylphenyl)methanone (CAS: 2789-44-8) represents a compound with significant potential in chemical biology and drug discovery. Ongoing research continues to uncover its diverse applications, from enzyme inhibition to anti-inflammatory effects, paving the way for its future use in therapeutic development. Continued interdisciplinary collaboration will be essential to fully realize its potential and overcome existing challenges.

• 832712-03-5(Cyclohexanone, 2-benzoyl-, (2S)-)
• 137471-32-0(Ethanone, 2-[(1R,2S)-2-benzoylcyclohexyl]-1-phenyl-, rel-)
• 690660-87-8(Cyclohexanone, 2-benzoyl-3-ethyl-, (2R,3S)-rel- (9CI))
• 16094-85-2(Cyclohexanone, 2,6-dibenzoyl-)
• 137448-42-1(Ethanone, 2-[(1R,2R)-2-benzoylcyclohexyl]-1-phenyl-, rel-)
• 129139-66-8(Cyclohexanone, 3-(1-methyl-2-oxo-2-phenylethyl)-)
• 898769-18-1(Cyclohexyl 3,5-dimethylphenyl ketone)
• 23611-59-8(Cyclohexanone, 2-(4-methylbenzoyl)-)
• 832712-04-6(Cyclohexanone, 2-benzoyl-, (2R)-)
• 24740-01-0(Cyclohexanone, 2-(3-oxo-3-phenylpropyl)-)